The Prevalence of Migraine in Iran: A Systematic Review and Meta-Analysis
نویسندگان
1 School of Medicine, Babol University of Medical Sciences, Babol, IR Iran
2 Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, IR Iran
3 Department of Public Health, Faculty of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, IR Iran
4 Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, IR Iran
5 Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, IR Iran
6 Hamadan University of Medical Sciences, Hamadan, IR Iran
7 Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, IR Iran
8 Social Determinants in Health Promotion Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
9
doi
چکیده
Context: Migraine is a major dilemma and problem which affects public health and results to reduced quality of life. This studyaimed to determine the prevalence of migraine in Iran.Evidence Acquisition: A systematic search was conducted using Pub Med,Web of Science, Embase, Scopus, Ovid, Google Scholar, aswell as Iranian databases including: MagIran, IranMedex and Scientific Information Databank, from 2000 to November, 2015. TheDer-Simonian/Laird’s random-effects model, with a 95% confidence intervalwasemployed to estimate the overall pooled prevalence.Heterogeneity was investigated using subgroup analysis based on sample size and time of study.Results: Thirty studies comprising 33,873 participants met the inclusion criteria for the analysis. The overall prevalence of migrainein Iran was 14% (95% CI, 12% to 17%), respectively. The overall prevalence was (8%; 95% CI 6% to 11%) according to the internationalclassification of headache disorders (ICHD-1), (17%; 95% CI 13% to 21%) according to ICHD-2, and (18%; 95% CI 7% to 30%) accordingto the other questionnaire for migraine screener (ID Migraine), respectively. Meta-regression demonstrated that the prevalence ofmigraine increased by year of publication and decreased by sample size.Conclusions: The prevalence of migraine in Iran, which was estimated as 14%, was similar or even higher than that reported worldwide.Migraine can have impact on the economic productivity of any country; therefore it is necessary to educate people on theearly detection and the discovery of an effective treatment of migraine. More thorough review of further studies in this field isrecommended.
